15 Multiple Sclerosis Clinical Trials in Phoenix, AZ (2026)

Q: How do I join a clinical trial in Phoenix?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you.

Recruiting Multiple Sclerosis Studies in Phoenix

NCT06433752Recruiting

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting...

Phoenix, AZ2,000 participantsTG Therapeutics, Inc.

View Study Details

NCT06401330Recruiting

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)

This phase III trial studies using risk factors in determining treatment for children with favorable tissue (histology) Wilms tumors (FHWT). Wilms Tumor is the most common type of kidney cancer in chi...

Phoenix, AZPHASE31,656 participantsChildren's Oncology Group

View Study Details

NCT07213804Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

This is a clinical study that has three parts. It is testing a potential new medicine called Sofetabart Mipitecan (Sofe-M) for people with certain types of ovarian, peritoneal, and fallopian tube canc...

Phoenix, AZPHASE31,630 participantsEli Lilly and Company

View Study Details

NCT07225504Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

The purpose of this study is to provide efficacy and safety data for remibrutinib in patients with secondary progressive multiple sclerosis (SPMS)...

Phoenix, AZPHASE31,275 participantsNovartis Pharmaceuticals

View Study Details

NCT07299019Recruiting

A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

Orelabrutinib is a CNS-penetrable BTK inhibitor. This is a phase 3, randomized, double-blind, parallel-group, multicenter study to evaluate the efficacy and safety of orelabrutinib compared with place...

Phoenix, AZPHASE3990 participantsZenas BioPharma (USA), LLC

View Study Details

NCT06131840Recruiting

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like your lungs or liver instead of your blood. Once tumors have grown bigger in one p...

Phoenix, AZPHASE1914 participantsSeagen, a wholly owned subsidiary of Pfizer

View Study Details

NCT07222800Recruiting

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

The purpose of this study is to learn more about a new medicine called PF-08634404, and how well it works in people with cancer of the colon or rectum (CRC)). The goal is to understand if the new stud...

Phoenix, AZPHASE3800 participantsPfizer

View Study Details

NCT07214532Recruiting

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

The purpose of this study is to evaluate the efficacy and safety of ctDNA-guided initiation of CDK4/6 inhibitor therapy using the Signatera™ Designed on Genome test (referred to as "Signatera Genome")...

Phoenix, AZNA725 participantsNatera, Inc.

View Study Details

NCT07218926Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

The purpose of this study is to find out if a new drug, called IDRX-42 (also known as GSK6042981), is effective in treating adults with a type of cancer called Gastrointestinal Stromal Tumors (GIST) w...

Phoenix, AZPHASE3450 participantsGlaxoSmithKline

View Study Details

NCT04322318Recruiting

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

This phase II trial studies how well combination chemotherapy works in treating patients with newly diagnosed stage II-IV diffuse anaplastic Wilms tumors (DAWT) or favorable histology Wilms tumors (FH...

Phoenix, AZPHASE2256 participantsChildren's Oncology Group

View Study Details

NCT07173257Recruiting

PROMs After Pancreatectomy

The standard of care for a patient with resectable pancreatic is to perform pancreatic resection which, even in the modern era is associated with significant complications and impact on quality of lif...

Phoenix, AZ250 participantsUniversity of Arizona

View Study Details

NCT07325292Recruiting

Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis

This is a randomized, open-label, parallel, Phase 3 study with 2-arms for treatment. The purpose of this study is to evaluate SC administration of frexalimab every 4 weeks (q4w) compared to IV admini...

Phoenix, AZPHASE3160 participantsSanofi

View Study Details

NCT07129252Recruiting

A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

This Phase 1/2, multicenter, open-label, FIH study aims to evaluate the safety, tolerability, PK, and preliminary antitumor activity of CRN09682 in participants with SST2-expressing NENs and other sol...

Phoenix, AZPHASE1150 participantsCrinetics Pharmaceuticals Inc.

View Study Details

NCT07008118Recruiting

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

This study is being conducted to evaluate the safety and tolerability of INCA035784 in participants with myeloproliferative neoplasms....

Phoenix, AZPHASE1120 participantsIncyte Corporation

View Study Details

NCT07485205Recruiting

Establishing Normative Urodynamics Parameters for the Glean Urodynamics System in Healthy Adults

A prospective, open-label, single arm interventional trial to establish normative reference ranges for urodynamics parameters in healthy adult participants using using the Glean Urodynamics System....

Phoenix, AZNA72 participantsBright Uro

View Study Details

About Multiple Sclerosis Clinical Trials in Phoenix

Multiple sclerosis (MS) is an autoimmune disease where the immune system attacks the protective covering of nerve fibers, causing communication problems between the brain and body. Symptoms vary widely and can include vision problems, fatigue, and mobility issues. Disease-modifying therapies have significantly improved outcomes.

There are currently 15 multiple sclerosis clinical trials recruiting participants in Phoenix, AZ. These studies are seeking a combined 11,448 participants. Research is being sponsored by TG Therapeutics, Inc., Children's Oncology Group, Eli Lilly and Company and 11 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Multiple Sclerosis Clinical Trials in Phoenix — FAQ

Are there multiple sclerosis clinical trials in Phoenix?

Yes, there are 15 multiple sclerosis clinical trials currently recruiting in Phoenix, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Phoenix?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you about next steps.

Are clinical trials in Phoenix free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Phoenix studies also compensate for your time and travel.

What multiple sclerosis treatments are being tested?

The 15 active trials in Phoenix are testing new therapies including novel drugs, biologics, and treatment approaches for multiple sclerosis.

Data updated July 18, 2026 from ClinicalTrials.gov